Concord Drugs Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	3.36	4.72	9.86	15.94	32.82
Depreciation & Amortization	14.31	15.55	16.26	17.65	13.65
Other Operating Activities	21.65	17.95	15.16	13.84	1.61
Change in Accounts Receivable	-8.75	-40.17	128.79	-21.3	47.18
Change in Inventory	-23.46	-28.58	-6.86	-56.18	45.59
Change in Accounts Payable	43.64	-18.35	-85.48	40.31	-96.48
Change in Income Taxes	-0.18	-1.58	-3.24	2.01	3.52
Change in Other Net Operating Assets	-13.35	58.37	-57.85	-4.52	-47.89
Operating Cash Flow	37.22	7.92	16.63	7.74	0
Operating Cash Flow Growth	369.77%	-52.36%	114.81%	4778912.35%	-100.00%
Capital Expenditures	-23.33	-10.18	-8.57	-24.56	-36.74
Cash Acquisitions	-	-	-14.15	-	-
Investment in Securities	0.14	0.09	0.06	-	-
Other Investing Activities	0	-	-	0.12	36.74
Investing Cash Flow	-23.18	-10.09	-22.66	-24.44	-0
Short-Term Debt Issued	-	17.23	-	47.3	36.79
Long-Term Debt Issued	6.79	-	-	-	-
Total Debt Issued	6.79	17.23	-	47.3	36.79
Short-Term Debt Repaid	-0.8	-	-1.56	-	-
Long-Term Debt Repaid	-	-12.66	-0.35	-12.69	-2.74
Total Debt Repaid	-0.8	-12.66	-1.9	-12.69	-2.74
Net Debt Issued (Repaid)	5.99	4.57	-1.9	34.61	34.05
Issuance of Common Stock	-	6.85	18.87	-	-
Other Financing Activities	-20.27	-8.58	-10.72	-17.83	-13.31
Financing Cash Flow	-14.28	2.83	6.24	16.79	20.74
Miscellaneous Cash Flow Adjustments	-	-	-	-	-20.5
Net Cash Flow	-0.25	0.67	0.21	0.09	0.23
Free Cash Flow	13.89	-2.26	8.06	-16.82	-36.74
Free Cash Flow Margin	3.07%	-0.50%	1.55%	-2.85%	-7.14%
Free Cash Flow Per Share	1.39	-0.23	0.87	-1.92	-4.20
Cash Interest Paid	20.27	18.68	16.37	14.13	12.45
Cash Income Tax Paid	2.03	2.2	3.79	6.71	0
Levered Free Cash Flow	5.23	45.42	-22.88	-31.95	-76.43
Unlevered Free Cash Flow	17.22	56.77	-12.67	-22.08	-68.11
Change in Working Capital	-2.1	-30.3	-24.64	-39.68	-48.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.